Diabetes, Metabolomics, PTM, Phosphorylation, Gut (13)
1 Gastric Bypass Surgery May Improve Beta Cell Apoptosis with Ghrelin Overexpression in Patients with BMI >/= 32.5 kg/m
2 A refined-JinQi-JiangTang tablet ameliorates prediabetes by reducing insulin resistance and improving beta cell function in mice.
3 NF-kappaB and STAT1 control CXCL1 and CXCL2 Gene Transcription.
4 Tungstate promotes beta-cell survival in Irs2-/-mice.
5 Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass.
6 Chromogranin A is a T cell antigen in human type 1 diabetes.
7 Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery?
8 Attenuation of berberine on lipopolysaccharide-induced inflammatory and apoptosis responses in beta-cells via TLR4-independent JNK/NF-kappaB pathway.
9 Defective prolactin signaling impairs pancreatic beta-cell development during the perinatal period.
10 Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: Mechanisms of Diabetes Remission and Role of Gut Hormones.
11 Do post-translational beta cell protein modifications trigger type 1 diabetes?
12 TGF-beta superfamily member nodal stimulates human beta-cell proliferation while maintaining cellular viability.
13 Long-Term Effects of Bariatric Surgery on Meal Disposal and beta-Cell Function in Diabetic and Nondiabetic Patients.

















返回本期 [全部]